Greg Simon, MD, MPH, is a psychiatrist and senior investigator well-known for his extensive research on practical approaches to improving mental health care. He seeks to develop and evaluate effective real-world strategies that support better mental health and wellness. Current areas of emphasis include identifying and assessing suicide risk, improving care for treatment-resistant depression, and early intervention for mental health conditions in children and youth.
Dr. Simon leads the Mental Health Research Network (MHRN), a consortium of research centers affiliated with 13 large health systems across the United States, including Kaiser Permanente Washington. This network, funded through a cooperative agreement with the National Institute of Mental Health, aims to improve the efficiency, relevance, and impact of mental health clinical and health services research. Now in its second five-year funding cycle, the MHRN is exploring a broad range of issues—including suicide prevention, improving heart health in people with serious mental illness, using electronic medical records to improve follow-up care for depression, and understanding the causes of racial and ethnic disparities in mental health care.
Dr. Simon and his MHRN colleagues are conducting several large studies across MHRN health systems, including:
Dr. Simon is an editor for the Cochrane Collaboration’s depression and anxiety review group, sits on the editorial board for General Hospital Psychiatry, and serves on the advisory board for the National Institutes of Health’s All of Us Program (formerly Precision Medicine Initiative). Earlier, he served on the editorial boards of Psychiatric Services and Psychological Medicine and chaired the scientific advisory board for the Depression and Bipolar Support Alliance. Dr. Simon has practiced adult psychiatry in Kaiser Permanente Washington's Mental Health and Wellness Service since 1990 and is a research professor in psychiatry and behavioral sciences at the University of Washington.
Depression; bipolar disorder; suicide prevention; self-management; treatment adherence
Comorbidity of mental health conditions with obesity, diabetes, heart disease, and substance use disorders.
Katon W, Von Korff M, Lin E, Walker E, Simon G, Robinson P, Bush T, Irvin S. Methodologic issues in randomized trials of liaison psychiatry in primary care. Psychosom Med. 1994;56(2):97-103. PubMed
Fogerty J, Engel C, Russo J, Simon G, Katon W. Hypertension and pheochromocytoma testing: the association with anxiety disorders. Arch Fam Med. 1994;3:55-60.
Simon GE, VonKorff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry. 1993;15(6):399-408. PubMed
Simon GE, Daniell W, Stockbridge H, Claypoole K, Rosenstock L. Immunologic, psychologic and neuropsychologic factors in multiple chemical sensitivity: a controlled study. Ann Intern Med. 1993;119(2):97-103. PubMed
Simon GE, Revicki D, VonKorff M. Telephone assessment of depression severity. J Psychiatr Res. 1993;27(3):247-52. PubMed
Simon GE. Epidemic multiple chemical sensitivity in an industrial setting. Toxicol Ind Health. 1992;8(4):41-6. PubMed
Simon GE. Psychiatric treatments in multiple chemical sensitivity. Toxicol Ind Health. 1992;8(4):67-72. PubMed
Simon GE, VonKorff M. Reevaluation of secular trends in depression rates. Am J Epidemiol. 1992;135(12):1411-22. PubMed
Simon GE. Psychiatric disorder and functional somatic symptoms as predictors of health care use. Psychiatr Med. 1992;10(3):49-59. PubMed
Simon GE, VonKorff M. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area Study. Am J Psychiatry. 1991;148(11):1494-500. PubMed
Safety planning and risk screening improved outcomes for adult patients.
A new grant funds modeling work to make personalized treatment possible.
KPWHRI research finds ways to increase use of a firearm safety tool.
Study finds that many patients who might benefit from clozapine don’t receive it.
KPWHRI researchers are contributing to better mental health care for people nationwide.